Compare BLMN & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLMN | THQ |
|---|---|---|
| Founded | 1988 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 851.9M | 784.0M |
| IPO Year | 2012 | N/A |
| Metric | BLMN | THQ |
|---|---|---|
| Price | $10.26 | $18.81 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $11.86 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 127.0K |
| Earning Date | 11-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | ★ 106.71 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $4,213,346,000.00 | N/A |
| Revenue This Year | $0.65 | N/A |
| Revenue Next Year | $1.66 | N/A |
| P/E Ratio | $9.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.19 | $16.28 |
| 52 Week High | $12.63 | $20.39 |
| Indicator | BLMN | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 65.08 | 58.03 |
| Support Level | $7.74 | $18.40 |
| Resistance Level | $11.75 | $19.05 |
| Average True Range (ATR) | 0.46 | 0.34 |
| MACD | 0.22 | 0.16 |
| Stochastic Oscillator | 88.63 | 91.52 |
Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.